Yuhan Liu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 8
- Molecular Biology top 10%
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 7
- Circular RNAs in diseases 6
- Ubiquitin and proteasome pathways 5
- RNA Research and Splicing 5
-
- Microtubule and mitosis dynamics 4
- Journals
- Advanced Science (4 papers)BioMed Research International (3 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Yuhan Liu
72 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 417
- Molecular Biology 768
- Immunology 143
- Oncology 157
- Toxicology 16
Countries citing papers authored by Yuhan Liu
This map shows the geographic impact of Yuhan Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhan Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhan Liu more than expected).
Fields of papers citing papers by Yuhan Liu
This network shows the impact of papers produced by Yuhan Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhan Liu. The network helps show where Yuhan Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuhan Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 4 | |
| 10 | 2024 | 4 | |
| 11 | 2024 | 0 | |
| 12 | 2023 | 10 | |
| 13 | 2023 | 8 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 17 | |
| 16 | EMT‐associated microRNAs and their roles in cancer stemness and drug resistancebreakdown → | 2021 | 246 |
| 17 | 2021 | 78 | |
| 18 | 2019 | 41 | |
| 19 | 2018 | 13 | |
| 20 | Expression of TPX2 and Aurora A in esophageal squamous carcinoma and their significance in clinical pathology. | 2009 | 2 |
About Yuhan Liu
Yuhan Liu is a scholar working on Cancer Research, Acoustics and Ultrasonics and Molecular Biology, having authored 81 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (8 papers), Epigenetics and DNA Methylation (7 papers), Circular RNAs in diseases (6 papers), Ubiquitin and proteasome pathways (5 papers), RNA Research and Splicing (5 papers) and Microtubule and mitosis dynamics (4 papers). The work is most often cited by research in Cancer Research (417 citations), Molecular Biology (768 citations) and Immunology (143 citations). Yuhan Liu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Shenglan Yang, Guangtao Pan, Luorui Shang, Fangyuan Zhou, Hongbing Mei, Yuchen Liu, Xin Hou, Yafei Shi, Xiaoxia Yang and Jiabin Zhou. Their work appears in journals such as Advanced Science, BioMed Research International, Scientific Reports, Nature Communications and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.